Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol

BMC Pediatrics

Table 1 Treatment results of representative pediatric solid tumors after the first relapse

Tumor types	Number of cases	MST (months)	OS		Ref.
Tumor types	Number of cases	MST (months)	%	Year	Ref.
Neuroblastoma	2266	–	20	5	[22]
Neuroblastoma	357	10	14	10	[23]
Hepatoblastoma	59	12	43	3	[24]
Rhabdomyosarcoma	605	10	17	5	[25]
Rhabdomyosarcoma	125	15	28	5	[26]
Ewing’s sarcoma	107	12	19	5	[27]
Ewing’s sarcoma	55	–	23	5	[28]
Osteosarcoma	43	15	35	3	[29]
Nephroblastoma	170	–	48	5	[30]

ISSN: 1471-2431